Vadivel Parthsarathy

Vadivel Parthsarathy is a Senior Lecturer in Biomedical Health at the College of Science and Engineering. His research focuses on the development and evaluation of marine-derived peptides and synthetic analogues for antidiabetic and neuroprotective applications. He has extensively studied the therapeutic potential of apelin-13, xenin, and GIP analogues in diabetic mouse models, examining their effects on insulin secretion, glucose homeostasis, and metabolic dysfunction.

• Specializes in marine biotechnology and peptide therapeutics
• Collaborates on diabetes pharmacology and neurodegenerative disease research
• Key methodologies: DPP-4 inhibition, incretin hormone stability, and enzyme-resistant peptide design

His publications highlight trends in multi-receptor targeting therapies (e.g., APJ and GLP-1 co-agonists) and natural product optimization for metabolic diseases. Collaborative work also explores neuroprotective effects of diabetes drugs like liraglutide in Alzheimer’s models.